Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia - CEPHEUS

Study identifier:NIS-SA-CRE-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia

Medical condition

Hypercholesterolemia

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

4053

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Nov 2009
Primary Completion Date: 01 May 2010
Study Completion Date: 01 May 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

ClinArt Company & Signen Clinical Discoveries

Inclusion and exclusion criteria